Interestingly, although PI3K mutations are seen in primary breast angiosarcomas and MYC mutations are often seen in radiation-associated angiosarcomas, in our study, PI3K and MYC mutations did not exhibit statistically significant mutual exclusivity [27,30]. This evidence concerns the gene PIK3CA and breast angiosarcoma.